Pharyngeal Neoplasms - 58 Studies Found Recruiting : ADjuVant Apatinib in Nasopharyngeal Carcinoma Patients With Residual Epstein-Barr Virus (EBV) DNA Following Radiotherapy : Nasopharyngeal Neoplasms : 2016-08-01 : Drug: Apatinib Patients will t Recruiting : Clinical Target Volume Based on Disease Extension Risk Atlas and Computer-aided Delineation in Nasopharyngeal Carcinoma : Nasopharyngeal Neoplasms : 2015-12-03 : Radiation: IMRT using individualized CTV Completed : The Value of Diagnosis and Outcome Prediction in CTC for Metastatic NPC Patients : Nasopharyngeal Neoplasms : 2015-07-20 : Other: the number of circulating tumor cells Completed : Combination of Docetaxel, Cisplatin, and Capecitabine (DCX) in the Treatment of Nasopharyngeal Carcinoma : Nasopharyngeal Neoplasms : 2015-02-03 : Drug: Docetaxel 75mg/㎡, Active, not recruiting : Safety and Efficacy of Oral Azacitidine in Previously Treated Subjects With Locally Advanced or Metastatic Nasopharyngeal Carcinoma : Nasopharyngeal Neoplasms : 2014-10-17 : Drug: CC-486 Other Name: oral azacitidine Recruiting : Efficacy and Safety of TC+AVASTIN Versus TC in Patients With Metastatic Nasopharyngeal Carcinoma : Nasopharyngeal Neoplasms : 2014-08-26 : Drug: Paclitaxel Paclitaxel 17 Recruiting : Dose-finding Study of Abraxane in Combination With Cisplatin to Treat Advanced Nasopharyngeal Carcinoma : Nasopharyngeal Neoplasms : 2012-11-22 : Drug: ABX + DDP ABX 260 mg/m2 Active, not recruiting : Effect and Safety Study of GP/FP Regimens in Advanced Nasopharyngeal Carcinoma : Nasopharyngeal Neoplasms : 2012-01-31 : Drug: gemcitabine and cisplatin Completed : Peptide Vaccine to Prevent Recurrence of Nasopharyngeal Cancer : Nasopharyngeal Neoplasms : 2004-02-27 : Drug: EBV-LMP-2 Completed : Environmental and Genetic Determinants of NPC : Nasopharyngeal Neoplasms Herpesvirus 4, Human : 2010-12-08 <<< Previous | Next >>>
